Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
As at 2021-12-31 |
2021-01-01 to 2021-12-31 |
As at 2020-12-31 |
|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |||
| Name of reporting entity or other means of identification | — |
Egetis Therapeutics AB
|
— |
| Legal form of entity | — |
AB
|
— |
| Country of incorporation | — |
Sverige
|
— |
| Address of entity's registered office | — |
Klara Norra Kyrkogata 26
|
— |
| Principal place of business | — |
111 22 Stockholm
|
— |
| Description of nature of entity's operations and principal activities | — |
Egetis är ett innovativt och integrerat läkemedelsbolag, fokuserat på projekt i sen klinisk
|
— |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
| Current inventories |
694,000
SEK
|
— |
3 138
SEK
|
| Current trade receivables |
3 456
SEK
|
— |
3 883
SEK
|
| Current trade payables |
4 596
SEK
|
— |
15 611
SEK
|